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 Implication for health policy/practice/research/medical education:
Hepatitis D infection aggregates chronic hepatitis B infection in the patients. This article about super and co-infection of HDV is 
recommended for medical practitioners and specialists in the ﬁeld of hepatologists as well as health policy makers.
Background: Hepatitis D virus (HDV) is a defective RNA virus that depends on the hepa-
titis B surface antigen (HBsAg) of hepatitis B virus for its replication, developing exclu-
sively in patients with acute or chronic hepatitis B. There are little data regarding the 
routes of HDV transmission in Iran. The risk factors for HDV infection in Iran are blood 
transfusion, surgery, family history, Hejamat wet cupping (traditional phlebotomy), tat-
tooing, war injury, dental interventions, and endoscopy.
Objectives: We performed this study to determine the prevalence of hepatitis D in the 
general population of Qom province and the potential risk factors for acquiring HDV.
Patients and Methods: This cross-sectional study collected 3690 samples from 7 rural 
clusters and 116 urban clusters. HBs antigen was measured, and if the test was positive, 
anti-HDV was measured. Ten teams, each consisting of 2 trained members, were assigned 
to conduct the sampling and administer the questionnaires. The data were analyzed us-
ing SPSS.
Results: Forty-eight subjects (1.3%) suﬀered from hepatitis B, and 1 HBsAg-positive case 
had HDV infection. The prevalence of hepatitis D infection in Qom Province was 0.03%. 
The prevalence of hepatitis D infection in HBsAg-positive cases was 2%. Our anti-HDV-pos-
itive case had a history of tattooing, surgery, and dental surgery. There was no signiﬁcant 
relationship between tattooing, surgery history, or dental surgery and hepatitis D infec-
tion. 
Conclusions: The prevalence of hepatitis D in Qom is the the lowest in Iran, similar to a 
study in Babol (north of Iran). 
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1. Background
Hepatitis D virus (HDV) is a defective RNA virus that de-
pends on the hepatitis B surface antigen (HBsAg) of hepa-
titis B virus for its replication, developing exclusively in 
patients with acute or chronic hepatitis B. Simultaneous 
infection with HDV tends to accelerate the progression 
of chronic hepatitis B virus (HBV) to chronic active hepa-
titis, cirrhosis, and hepatocellular carcinoma and me-
diates fulminant hepatitis. In addition, the response of 
HDV patients to antiviral therapy and the required dos-
ages of therapeutic regimens diﬀer from those of chronic 
hepatitis B alone (1, 2). Approximately 5% of patients with 
chronic hepatitis B infection worldwide are infected with 
hepatitis D virus. Its prevalence in Italy, eastern Europe, 
and western Asia is higher than in the rest of the world, 
reaching 83.3%, 8.3%, and 12.5% in Romania, Italy, and Rus-
sia, respectively (2-4). Hepatitis D virus (HDV) has a broad 
geographical distribution, with 2 dominant patterns 
of transmission. In endemic regions, such as southern 
Italy, parts of Africa, and South America, it is transferred 
through close personal contact in the absence of clear 
skin contact, such as close personal relationships among 
members of a family. In contrast, in areas that have a low 
prevalence, such as western Europe and North America, 
HDV is seen more commonly in groups with frequent 
skin contact, such as continual recipients of blood and 
blood products and intravenous drug users (5, 6). Sexual 
transmission and maternal-child transmission are other 
modes (1, 7). There are little data regarding the routes of 
HDV transmission in Iran. The predominant routes of the 
transmission of HBV in Iran are maternal, from infected 
mothers to infants, and horizontally during childhood 
(8). The epidemiology of hepatitis B has shifted in Iran, 
and horizontal transmission in adults is increasing (9). 
The risk factors for HDV infection in some studies in Iran 
have been blood transfusion, surgery, family history, wet 
cupping Hejamat (traditional phlebotomy) ,tattooing, 
war injury, dental interventions, and endoscopy (5, 6). 
The most frequent method of diagnosing HDV infection 
is the measurement of anti-HDV (IgM, IgG) in serum by 
ELISA. PCR can also be used to detect viral RNA in blood 
(10, 11). Acute HDV infection can occur simultaneously 
with acute HBV infection or can be superimposed onto 
chronic HBV infection. Fatal fulminant hepatitis occurs 
in 20% to 30% of coinfections of HDV and HBV in humans 
versus 2% of patients with acute hepatitis B without HDV 
coinfection (7). 
2. Objectives
We performed this study to determine the prevalence 
of hepatitis D in the general population of Qom province 
(center of Iran) and the potential risk factors for acquir-
ing HDV.
3. Patients and Methods
This study was a cross-sectional descriptive study. A 
population of 3960 individuals was assigned to the study 
by cluster sampling. Seven rural clusters and 116 urban 
clusters were established, based on girls’ elementary 
schools in diﬀerent districts of the province. The clusters 
were selected according to the proportion of urban and 
rural populations in Qom. From each cluster, 30 blood 
specimens were obtained. For sampling purposes, only 1 
person from each family was selected randomly by draw 
of the lots. Then, the phases of the study were explained 
to the individuals who were eligible for the study. Those 
who were interested were invited to undergo tests and 
complete questionnaires. The inclusion criteria were 
HbsAg positivity, and those who were not Iranian were 
excluded. After obtaining written consent from the can-
didates, a questionnaire, including such data as age; sex; 
marital status; and history of blood transfusion, surgery, 
dental surgery, viral hepatitis, immunization, narcotic 
drug abuse, smoking, tattooing, cupping, and endosco-
py, was completed for each candidate. Nearly 5 cc of se-
rum was taken from each subject and transferred to the 
lab under sterile conditions in ice bags. HBs antigen was 
measured at the lab, and if the test was positive, anti-HDV 
was measured by ELISA (Biovendor, Germany). Ten teams 
of 2 trained members were responsible for preparing the 
samples and completing the questionnaires. Categorical 
variables were analyzed by Pearson chi-square test and 
Fisher exact test. The data were analyzed using SPSS, and 
P < 0.05 was considered signiﬁcant.
4. Results
This study determined the prevalence of hepatitis D in 
Qom Province. Only 1 patient was infected with hepatitis 
D. Of the 3690 subjects, 48 (1.3%) suﬀered from hepatitis 
B. Fifty-six percent of HBsAg-positive cases were male 
(Table 1). Thus, 2% of infected patients and 0.03% of the en-
tire group had HDV infection. Our anti-HDV-positive case 
was a married 31-year-old woman who lived in Qom who 
originated from Afghanistan and had a history of tattoo-
ing, surgery, and dental surgery. By Fisher test, there was 
a signiﬁcant relationship between tattooing and hepati-
tis D infection in the entire population (P = 0.045), but 
there was no signiﬁcant relationship between surgical 
history or dental surgical history and hepatitis D in the 
entire group (P > 0.05). Of cases with an HBsAg-positive 
test, there was no signiﬁcant relationship between tat-
tooing, surgical history, or dental surgical history and 
hepatitis D infection (P > 0.0586).
5. Discussion
There are data from diﬀerent parts of the country re-
porting disparate prevalence rates. In a study by Male-
kzadeh et al. in asymptomatic hepatitis B carriers in Shi-
raz (South of Iran), 13.9% was positive for anti-HDV (12). 
This was the ﬁrst report on the epidemiology of HDV in-
fections from Iran. In a new study by Taghavi et al. in Shi-
raz in chronic hepatitis B patients over the age of 15 years 
old, the anti-HDV positivity rate was 9.7%, demonstrating 
a decrease in prevalence (13). Amini et al. reported that 207 Hepat Mon. 2012
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2.4% of HBsAg carriers in Hamadan (midwest of Iran) 
were positive for anti-HDV—a low prevalence of HDV 
infection. Positive HDV cases were mainly children and 
young adults (< 20 years of age), suggesting that super-
infection or coinfection with HDV occurred in childhood 
or early adolescence (14). In a study in Tehran, Rezvan 
et al. reported that 2.4% of HBsAg-positive blood donors 
and 44.5% of hemodialysis patients with HBsAg had anti-
HDV (15). Karimi et al. reported that 1.3% of HBsAg-positive 
blood donors and 25.2% of hemodialysis patients with 
HBsAg were positive for anti-HDV in Tehran (16). Alavian 
et al . reported that 5.7% of chronic hepatitis B patients in 
Tehran (capital of Iran) were anti-HDV-positive. A history 
of transfusion, surgical history, tattooing, war injury, 
dental interventions, and endoscopy were common in 
HDV infection and were the risk factors (5)  ċC. Roshandel 
et al. reported that 5.8% of HBsAg-positive individuals 
had anti-HDV in Golestan (17-19). Hasanjani Roushan et 
al. reported that 2% of chronic hepatitis B patients were 
anti-HDV-positive in Babol (north of Iran) (20), whereas 
Zahedi et al. reported that 20.7% of chronic hepatitis B pa-
tients were anti-HDV-positive in Kerman (south of Iran) 
(21). Torabi et al. reported a prevalence of 6.15% for anti-
HDV-positivity in chronic hepatitis B patients in Tabriz 
(northwest of Iran) (22). Vaziri et al. noted a prevalence 
of 31.57% for anti-HDV positivity in HIV patients who were 
coinfected with HBV in Kermanshah (west of Iran) (23). 
Ataei  et al. reported that there was no association be-
tween hepatitis D and probable risk factors (24). In con-
clusion, HDV infection is a widespread disease that has af-
HBs-Ag Positive, No. (%) HDV-Ab Positive, No. (%) P value
Gender > 0.05
Male
Female
27 (56)
21 (44)
0 (0.00)
1 (4.7)
Drug Addiction > 0.05
Yes
Occasionally
No
0 (0.00) 
2 (4.34) 
44 (95.6)
0 (0.00) 
0 (0.00) 
1 (2.27)
Smoking > 0.05
Yes
No
7 (14.58)
41 (85.41)
0 (0.00)
1 (2.43)
Tattooing > 0.05a
Yes
No
6 (12.5)
42 (87.5)
1 (16.66) 
0 (0.00)
Marital Status > 0.05
Single
Married
6 (13.63) 
38 (86.36)
0 (0.00) 
1 (98.61)
Transfusion History > 0.05
Yes
No
2 (4.25) 
45 (95.74)
0 (0.00) 
1 (2.22)
Dialysis History > 0.05
Yes
No
0 (0.00)
47 (1.00)
0 (0.00) 
1 (2.12)
Surgery History > 0.05
Yes
No
1 (2.17) 
45 (97.82)
1 (100.00) 
0 (0.00)
Cupping History > 0.05
Yes
No
6 (12.5) 
42 (87.5)
0 (0.00) 
1 (2.38)
Dental Procedure History >0.05
Yes
No
29 (60.41) 
19 (39.58)
1 (3.44) 
0 (0.00)
Endoscopic History > 0.05
Yes
No
7 (14.58)
41 (85.41)
0 (0.00)
1 (2.43)
Table 1. Seoprevalence of HBs Antigen and HDV Antibody According to Demographic Characteristics in Qom, Iran
a P value in whole subjects = 0.045208 Hepat Mon. 2012
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fected a large number of the HBV-infected population in 
Iran and is considered to be a major public health prob-
lem in Iran. The heterogeneous geographic distribution 
of HDV infection throughout the country indicates that 
the risk factors of HDV infection diﬀer between regions 
of the country and that comprehensive surveys in HBV-
infected patients should be conducted to determine the 
risk factors and prevalence of infection (25). This study 
showed that the prevalence of HDV in Qom province is 
low versus other provinces in Iran—the Roushan study in 
Babol. The lowest rate of HDV was in Qom (center of Iran) 
and Babol (north of Iran). Although our positive case had 
a history of tattooing, surgery, and dental surgery, the 
only signiﬁcant relationship in the entire population 
was between HDV infection and tattooing (P = 0.045); 
there was no signiﬁcant relationship between the other 
risk factors and HDV infection in the entire population or 
in the HBsAg-positive cases (P > 0.05).
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